NYSE: DHRDanaher Corp Stock Forecast, Predictions & Price Target
Analyst price target for DHR
Based on 12 analysts offering 12 month price targets for Danaher Corp.
Min Forecast
$154.00-32.17%
Avg Forecast
$205.58-9.45%
Max Forecast
$240.00+5.71%
Should I buy or sell DHR stock?
Strong Buy
Strong Buy
10 analysts 76.92%
Buy
2 analysts 15.38%
Hold
1 analysts 7.69%
Sell
0 analysts 0.00%
Strong Sell
0 analysts 0.00%
Forecast return on equity
Is DHR forecast to generate an efficient return?
Company
12.91%
Industry
26.10%
Market
13.94%
DHR's Return on Equity is forecast to be low in 3 years (12.91%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast
Forecast return on assets
Is DHR forecast to generate an efficient return on assets?
Company
6.57%
Industry
10.05%
Market
10.01%
DHR is forecast to generate lower Return on Assets (6.57%) than the US Diagnostics & Research industry average (10.05%)
Forecast
DHR earnings per share forecast
What is DHR's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$5.48+15.45%
Avg 2 year Forecast
$6.34+33.55%
Avg 3 year Forecast
$6.71+41.26%
DHR's earnings are forecast to grow at a rate of 14.56% per year, which is not exceptional
Forecast
DHR revenue forecast
What is DHR's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$21.3B+21.52%
Avg 2 year Forecast
$23.8B+35.68%
Avg 3 year Forecast
$24.6B+40.69%
DHR's revenue is forecast to grow at a rate of 15.43% per year, which is not exceptional
Forecast
DHR earnings growth forecast
How is DHR forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
14.56%
Industry
32.89%
Market
15.17%
DHR's earnings are forecast to grow slower (14.56% per year) than the US Diagnostics & Research industry average (32.89%)
Forecast
DHR's earnings are forecast to grow slower (14.56% per year) than the US market average (15.17%)
Forecast
DHR revenue growth forecast
How is DHR forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
15.43%
Industry
11.53%
Market
3.03%
DHR's revenues are forecast to grow faster (15.43% per year) than the US Diagnostics & Research industry average (11.53%)
Forecast
DHR's revenues are forecast to grow faster (15.43% per year) than the US market average (3.03%)
Forecast
Danaher Corp Stock Forecast FAQ
Is Danaher Corp Stock a good buy in 2020, according to Wall Street analysts?
The consensus among 13 Wall Street analysts covering (NYSE: DHR) stock is to Strong Buy DHR stock.
Out of 13 analysts, 10 (76.92%) are recommending DHR as a Strong Buy, 2 (15.38%) are recommending DHR as a Buy, 1 (7.69%) are recommending DHR as a Hold, 0 (0.00%) are recommending DHR as a Sell, and 0 (0.00%) are recommending DHR as a Strong Sell.
What is DHR's Price Target?
According to 12 Wall Street analysts that have issued a 1 year DHR price target, the average DHR price target is $205.58, with the highest DHR stock price forecast at $240.00 and the lowest DHR stock price forecast at $154.00.
On average, Wall Street analysts predict that Danaher Corp's share price could fall to $205.58 by Oct 8, 2021. The average Danaher Corp stock price prediction forecasts a potential downside of 9.45% from the current DHR share price of $227.03.
What is DHR's earnings growth forecast for 2020-2022?
(NYSE: DHR) Danaher Corp's forecast annual earnings growth rate of 14.56% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 32.89%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.17%.
Danaher Corp's earnings in 2020 is $3,372,100,000.On average, 8 Wall Street analysts forecast DHR's earnings for 2020 to be $3,824,942,085, with the lowest DHR earnings forecast at $3,731,684,840, and the highest DHR earnings forecast at $3,940,938,195. On average, 8 Wall Street analysts forecast DHR's earnings for 2021 to be $4,424,871,455, with the lowest DHR earnings forecast at $4,178,091,998, and the highest DHR earnings forecast at $4,743,076,058.
In 2022, DHR is forecast to generate $4,680,300,051 in earnings, with the lowest earnings forecast at $4,568,698,262 and the highest earnings forecast at $4,791,901,841.
What is DHR's revenue growth forecast for 2020-2022?
(NYSE: DHR) Danaher Corp's forecast annual revenue growth rate of 15.43% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 11.53%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 3.03%.
Danaher Corp's revenue in 2020 is $17,515,100,000.On average, 5 Wall Street analysts forecast DHR's revenue for 2020 to be $14,846,228,432,960, with the lowest DHR revenue forecast at $14,757,571,971,302, and the highest DHR revenue forecast at $14,948,208,753,274. On average, 5 Wall Street analysts forecast DHR's revenue for 2021 to be $16,576,364,471,704, with the lowest DHR revenue forecast at $16,246,430,521,020, and the highest DHR revenue forecast at $17,125,817,747,509.
In 2022, DHR is forecast to generate $17,187,620,726,056 in revenue, with the lowest revenue forecast at $17,140,437,581,946 and the highest revenue forecast at $17,234,803,870,165.
What is DHR's Earnings Per Share (EPS) forecast for 2020-2022?
(NYSE: DHR) Danaher Corp's current Earnings Per Share (EPS) is $4.75. On average, analysts forecast that DHR's EPS will be $5.48 for 2020, with the lowest EPS forecast at $5.35, and the highest EPS forecast at $5.65. On average, analysts forecast that DHR's EPS will be $6.34 for 2021, with the lowest EPS forecast at $5.99, and the highest EPS forecast at $6.80. In 2022, DHR's EPS is forecast to hit $6.71 (min: $6.55, max: $6.87).
What is DHR's forecast return on equity (ROE) for 2020-2022?
(NYSE: DHR) forecast ROE is 12.91%, which is considered weak.
What is DHR's forecast return on assets (ROA) for 2020-2022?
(NYSE: DHR) forecast ROA is 6.57%, which is lower than the forecast US Diagnostics & Research industry average of 10.05%.
©2020 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
